4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine

C127H128F6N28O6S — CID 161099527

IUPAC4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine
SMILESCn1c2c(c3ccc(F)cc31)CN(c1ccc(N3CCOCC3)nc1)CC2.Fc1ccc2[nH]c3c(c2c1)CN(c1ccc2nc(N4CCOCC4)ccc2c1)CC3.Fc1ccc2[nH]c3c(c2c1)CN(c1ccnc(N2CCOCC2)n1)CC3.Fc1ccc2[nH]c3c(c2c1)CN(c1cnc(N2CCOCC2)cn1)CC3.Fc1ccc2[nH]c3c(c2c1)CN(c1cnc2nc(N4CCOCC4)ccc2c1)CC3.Fc1ccc2c3c([nH]c2c1)CCN(c1ccc2nc(N4CCOCC4)sc2n1)C3
InChIInChI=1S/C24H23FN4O.C23H22FN5O.C21H20FN5OS.C21H23FN4O.2C19H20FN5O/c25-17-2-4-22-19(14-17)20-15-29(8-7-23(20)26-22)18-3-5-21-16(13-18)1-6-24(27-21)28-9-11-30-12-10-28;24-16-2-3-20-18(12-16)19-14-29(6-5-21(19)26-20)17-11-15-1-4-22(27-23(15)25-13-17)28-7-9-30-10-8-28;22-13-1-2-14-15-12-27(6-5-16(15)23-18(14)11-13)19-4-3-17-20(25-19)29-21(24-17)26-7-9-28-10-8-26;1-24-19-6-7-26(14-18(19)17-4-2-15(22)12-20(17)24)16-3-5-21(23-13-16)25-8-10-27-11-9-25;20-13-1-2-16-14(11-13)15-12-25(6-4-17(15)22-16)18-3-5-21-19(23-18)24-7-9-26-10-8-24;20-13-1-2-16-14(9-13)15-12-25(4-3-17(15)23-16)19-11-21-18(10-22-19)24-5-7-26-8-6-24/h1-6,13-14,26H,7-12,15H2;1-4,11-13,26H,5-10,14H2;1-4,11,23H,5-10,12H2;2-5,12-13H,6-11,14H2,1H3;1-3,5,11,22H,4,6-10,12H2;1-2,9-11,23H,3-8,12H2
InChIKeyUIFUVBGWOOOVSE-UHFFFAOYSA-N
MW2288.67 g/mol
LogP19.72
Rot. Bonds12

About 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine

4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine (PubChem CID 161099527) has the molecular formula C127H128F6N28O6S and a molecular weight of 2288.67 g/mol. Its IUPAC name is 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine.

Molecular Properties

Compound Name4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine
PubChem CID161099527
Molecular FormulaC127H128F6N28O6S
Molecular Weight2288.67 g/mol
Exact Mass2287.02
IUPAC Name4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine
SMILESCn1c2c(c3ccc(F)cc31)CN(c1ccc(N3CCOCC3)nc1)CC2.Fc1ccc2[nH]c3c(c2c1)CN(c1ccc2nc(N4CCOCC4)ccc2c1)CC3.Fc1ccc2[nH]c3c(c2c1)CN(c1ccnc(N2CCOCC2)n1)CC3.Fc1ccc2[nH]c3c(c2c1)CN(c1cnc(N2CCOCC2)cn1)CC3.Fc1ccc2[nH]c3c(c2c1)CN(c1cnc2nc(N4CCOCC4)ccc2c1)CC3.Fc1ccc2c3c([nH]c2c1)CCN(c1ccc2nc(N4CCOCC4)sc2n1)C3
InChIInChI=1S/C24H23FN4O.C23H22FN5O.C21H20FN5OS.C21H23FN4O.2C19H20FN5O/c25-17-2-4-22-19(14-17)20-15-29(8-7-23(20)26-22)18-3-5-21-16(13-18)1-6-24(27-21)28-9-11-30-12-10-28;24-16-2-3-20-18(12-16)19-14-29(6-5-21(19)26-20)17-11-15-1-4-22(27-23(15)25-13-17)28-7-9-30-10-8-28;22-13-1-2-14-15-12-27(6-5-16(15)23-18(14)11-13)19-4-3-17-20(25-19)29-21(24-17)26-7-9-28-10-8-26;1-24-19-6-7-26(14-18(19)17-4-2-15(22)12-20(17)24)16-3-5-21(23-13-16)25-8-10-27-11-9-25;20-13-1-2-16-14(11-13)15-12-25(6-4-17(15)22-16)18-3-5-21-19(23-18)24-7-9-26-10-8-24;20-13-1-2-16-14(9-13)15-12-25(4-3-17(15)23-16)19-11-21-18(10-22-19)24-5-7-26-8-6-24/h1-6,13-14,26H,7-12,15H2;1-4,11-13,26H,5-10,14H2;1-4,11,23H,5-10,12H2;2-5,12-13H,6-11,14H2,1H3;1-3,5,11,22H,4,6-10,12H2;1-2,9-11,23H,3-8,12H2
InChIKeyUIFUVBGWOOOVSE-UHFFFAOYSA-N
XLogP19.72
TPSA307.04 Ų
H-Bond Donors5
H-Bond Acceptors30
Rotatable Bonds12
Heavy Atoms168
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002288.67
LogP ≤ 519.72
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Analyze 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine?
The IUPAC name of 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine (CID 161099527) is 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine.
What is the SMILES notation for 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine?
The canonical SMILES for 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine is Cn1c2c(c3ccc(F)cc31)CN(c1ccc(N3CCOCC3)nc1)CC2.Fc1ccc2[nH]c3c(c2c1)CN(c1ccc2nc(N4CCOCC4)ccc2c1)CC3.Fc1ccc2[nH]c3c(c2c1)CN(c1ccnc(N2CCOCC2)n1)CC3.Fc1ccc2[nH]c3c(c2c1)CN(c1cnc(N2CCOCC2)cn1)CC3.Fc1ccc2[nH]c3c(c2c1)CN(c1cnc2nc(N4CCOCC4)ccc2c1)CC3.Fc1ccc2c3c([nH]c2c1)CCN(c1ccc2nc(N4CCOCC4)sc2n1)C3.
What is the InChIKey of 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine?
The InChIKey is UIFUVBGWOOOVSE-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H23FN4O.C23H22FN5O.C21H20FN5OS.C21H23FN4O.2C19H20FN5O/c25-17-2-4-22-19(14-17)20-15-29(8-7-23(20)26-22)18-3-5-21-16(13-18)1-6-24(27-21)28-9-11-30-12-10-28;24-16-2-3-20-18(12-16)19-14-29(6-5-21(19)26-20)17-11-15-1-4-22(27-23(15)25-13-17)28-7-9-30-10-8-28;22-13-1-2-14-15-12-27(6-5-16(15)23-18(14)11-13)19-4-3-17-20(25-19)29-21(24-17)26-7-9-28-10-8-26;1-24-19-6-7-26(14-18(19)17-4-2-15(22)12-20(17)24)16-3-5-21(23-13-16)25-8-10-27-11-9-25;20-13-1-2-16-14(11-13)15-12-25(6-4-17(15)22-16)18-3-5-21-19(23-18)24-7-9-26-10-8-24;20-13-1-2-16-14(9-13)15-12-25(4-3-17(15)23-16)19-11-21-18(10-22-19)24-5-7-26-8-6-24/h1-6,13-14,26H,7-12,15H2;1-4,11-13,26H,5-10,14H2;1-4,11,23H,5-10,12H2;2-5,12-13H,6-11,14H2,1H3;1-3,5,11,22H,4,6-10,12H2;1-2,9-11,23H,3-8,12H2.
What are the key properties of 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine?
4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine has a molecular weight of 2288.67 g/mol, XLogP of 19.72, 12 rotatable bonds, 5 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-(7-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,8-naphthyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[4-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrimidin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]morpholine is sourced from PubChem (CID 161099527), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).